Abstract:Xinxin Zhang, 1 Hui Wang, 1 Yajuan Han, 2 Mengqi Zhu, 1 Zaozhi Song, 1 Dankai Zhan, 1 Jianguang Jia 1 1 Department of Surgical Oncology, The First Affiliated Hospital of Bengbu Medical College, Bengbu 233000, People's Republic of China; 2 Department of Medical Oncology, The First Affiliated Hospital of Bengbu Medical College, Bengbu 233000, People's Republic of China Correspondence: Jianguang Jia Department of Surgical Oncology The First Affiliated Hospital of Bengbu Medical College, 2600 Donghai Road, Bengbu 233000, People's Republic of China Email Jiajianguang1978@126.com Purpose: Previous studies have shown that non-SMC condensin I complex subunit G ( NCAPG ) overexpression is correlated to poor prognosis of multiple cancer types. Herein, we explored the underlying mechanism of NCAPG -mediated cardia adenocarcinoma (CA) proliferation and cell cycle regulation. Methods: The protein profiling technology was used to analyze the gene expression in 20 CA and adjacent tissue samples. Differential genes were identified by bioinformatic analysis. Western blot and qRT-PCR-based analysis assessed the NCAPG expression levels in multiple CA cell lines. CA cell lines, SGC-7901 and AGS, were transfected with Lip 2000, and stably transfected cell lines were screened for NCAPG overexpression and downregulation. MTT and clone formation assays were employed to detect cell proliferation, and cell cycle phases were analyzed using flow cytometry. Western blot was performed to determine the NCAPG gene expression levels. Finally, we studied the tumorigenic effects of NCAPG in the mouse model and validated the cell experiment results using immunohistochemistry. Results: A significant overexpression of NCAPG was found in CA tissues and CA cell lines. The outcomes of MTT and clone formation assays showed that NCAPG upregulation promoted cell proliferation. The outcomes of these analyses were further validated using nude mice as an in vivo tumor model. As per the outcome of Western blot and flow cytometry analysis, NCAPG regulated the G1 phase through the cyclins (CDK4, CDK6, and cyclin D1) overexpression and cell cycle inhibitors (P21 and P27) downregulation. Overexpressed NCAPG and silenced NCAPG , both in vitro and in vivo, resulted in abnormal activation of the PI3K/AKT signaling pathway in CA cells. We observed that NCAPG overexpression increased the levels of phosphorylated PI3K, AKT, and GSK3β; however, their total protein levels remained unchanged in CA cells. Conclusion: As a CA oncogene, NCAPG promoted cell proliferation and regulated cell cycle through PI3K/AKT signaling pathway activation. Keywords: NCAPG , cardia adenocarcinoma, PI3K/AKT pathway, cell cycle, proliferation

The role of NCAPG in various of tumors

Important role and underlying mechanism of non‐SMC condensin I complex subunit G in tumours (Review)

NCAPG2 Promotes Tumour Proliferation by Regulating G2/M Phase and Associates with Poor Prognosis in Lung Adenocarcinoma

NCAPG as a Novel Prognostic Biomarker in Glioma

NCAPG facilitates colorectal cancer cell proliferation, migration, invasion and epithelial–mesenchymal transition by activating the Wnt/β-catenin signaling pathway

NCAPG Promotes Tumor Progression and Modulates Immune Cell Infiltration in Glioma

NCAPG2 Could Be an Immunological and Prognostic Biomarker: from Pan-Cancer Analysis to Pancreatic Cancer Validation

NCAPG promotes the progression of lung adenocarcinoma via the TGF-β signaling pathway

NCAPG promotes the oncogenesis and progression of non-small cell lung cancer cells through upregulating LGALS1 expression

NCAPG is a Promising Therapeutic Target Across Different Tumor Types

An Integrative Pan-Cancer Analysis Reveals the Carcinogenic Effects of NCAPH in Human Cancer.

Silencing non-SMC chromosome-associated polypeptide G inhibits proliferation and induces apoptosis in hepatocellular carcinoma cells

NCAPH serves as a prognostic factor and promotes the tumor progression in glioma through PI3K/AKT signaling pathway

NCAPG, Mediated by Mir-378A-3p, Regulates Cell Proliferation, Cell Cycle Progression, and Apoptosis of Oral Squamous Cell Carcinoma Through the GSK-3β/β-catenin Signaling.

NCAPD2 is a favorable predictor of prognostic and immunotherapeutic biomarker for multiple cancer types including lung cancer

NCAPG promotes proliferation of epithelial ovarian cancer by activating the NF-κB and AKT/mTOR pathways

NCAPG promotes tumorigenesis of bladder cancer through NF-κB signaling pathway

Correction: NCAPD2 is a Favorable Predictor of Prognostic and Immunotherapeutic Biomarker for Multiple Cancer Types Including Lung Cancer

NCAPH is upregulated in endometrial cancer and associated with poor clinicopathologic characteristics

NCAPG Induces Cell Proliferation in Cardia Adenocarcinoma via PI3K/AKT Signaling Pathway

NCAPG2 facilitates glioblastoma cells’ malignancy and xenograft tumor growth via HBO1 activation by phosphorylation